Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality

MLA

Bermejo-Martin, Jf, et al. Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....08a1cee10abe0caa974f5f543e7c4e9e&authtype=sso&custid=ns315887.

APA

Bermejo-Martin, J., Cilloniz, C., Mendez, R., Almansa, R., Gabarrus, A., Ceccato, A., Torres, A., Menendez, R., & NEUMONAC group. (2017). Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality.

Chicago

Bermejo-Martin, Jf, C Cilloniz, R Mendez, R Almansa, A Gabarrus, A Ceccato, A Torres, R Menendez, and NEUMONAC group. 2017. “Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....08a1cee10abe0caa974f5f543e7c4e9e&authtype=sso&custid=ns315887.